Search

Search Results

• Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

  Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

  e2012041

  2012-06-19

  https://doi.org/10.4084/mjhid.2012.041

  1164

  PDF: 775

  HTML: 762

• As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report

  Aylin Canbolat Ayhan, Korhan ozkan, Cetin Timur, Birol Aktaş, Ayse Bahar Ceyran

  e2013043

  2013-06-06

  https://doi.org/10.4084/mjhid.2013.043

  1797

  PDF: 651

  HTML: 1556

  Figure 1: MRI demonstrating Aspergillus synovitis: 204

  Figure 2:MRI demonstrating Aspergillus synovitis: 212

• Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

  Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca

  e2018001

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.001

  4309

  PDF: 1152

  HTML: 1032

• POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

  Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.028

  1182

  PDF: 622

  Suppl. Files: 142

  HTML: 479

• LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

  Andrea Riccardo Filippi

  e2016041

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.041

  3789

  PDF: 1146

  HTML: 2471

  Figure 1: 224

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3719

  PDF: 2600

  HTML: 1625

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2594

  PDF: 1744

  HTML: 534

• GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

  Francesco Fabozzi, Angela Mastronuzzi

  e2023032

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.032

  2110

  PDF: 549

  HTML: 609

• Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature

  Claudia Gomez-Hernandez, Carmen Corrales, Pedro José Mirete, Soraya Ramos, Mireia Micó-Cerdà, Clara Martinez-Lopez, Juan Carlos Hernandez-Boluda, Carlos Solano, Rafael de la Camara, Jose Luis Piñana

  e2026072

  2026-09-01

  https://doi.org/10.4084/MJHID.2026.072

  50

  PDF: 53

  Suppl. Files: 4

  Html: 5

  Html Suppl. Files: 1

• An unusual cause of anemia and encephalopathy

  Sanjeev Kumar Sharma, Dharma Choudhary, Anil Handoo, Gaurav Dhamija, Gaurav Kharya, Vipin Khandelwal, Mayank Dhamija, Sweta Kothari

  e2015036

  2015-04-24

  https://doi.org/10.4084/mjhid.2015.036

  4125

  PDF: 887

  HTML: 1537

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2561

  PDF: 821

  HTML: 1746

• LIGHT CHAIN AMYLOIDOSIS

  Paolo Milani, Giampaolo Merlini, Giovanni Palladini

  e2018022

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.022

  6142

  PDF: 2410

  HTML: 1552

• ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

  Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante

  e2022008

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.008

  2510

  PDF: 1221

  HTML: 1066

• MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

  Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo

  e2025064

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.064

  2566

  PDF: 1013

  HTML: 293

• INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE

  Duni Sawadogo, Aissata Tolo, Hermance Kassi, Mahawa Sangare, Andre Inwoley

  e2013023

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.023

  2064

  PDF: 777

  HTML: 723

  Table1: patient's characteristics: 175

  Table 2: profile of each patient: 198

• IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

  Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop

  e2009010

  2009-11-13

  https://doi.org/10.4084/mjhid.2009.010

  1274

  PDF: 625

  HTML: 6918

• Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

  Claudio Fozza

  e2024011

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.011

  1770

  PDF: 1417

  HTML: 191

• POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

  Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles

  e2010016

  2010-06-19

  https://doi.org/10.4084/mjhid.2010.016

  1215

  PDF: 795

  HTML: 589

• THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

  Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt

  e2017019

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.019

  4292

  PDF: 2019

  HTML: 1956

• DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE

  avinash kumar singh, tulika seth, nita radhakrishnan, pravas mishra, manoranjan mahapatra, haraprasad pati

  e2013039

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.039

  2547

  PDF: 877

  HTML: 3601

  Diamond Blackfan Anemia: A Tertiary care centre experience: 359

• IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

  Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno

  e2009006

  2009-10-27

  1685

  PDF: 684

  HTML: 43951

• CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN

  Naouel GUIRAT, Monia Ben Khaled, Monia Ouederni, Imen Ben-Mustapha, Ridha Kouki, Habib Besbes, Mohamed Ridha Barbouche, Fethi Mellouli, mohamed bejaoui

  e2018065

  2018-10-30

  https://doi.org/10.4084/mjhid.2018.065

  1942

  PDF: 1166

  HTML: 427

• HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

  Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando

  e2021011

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.011

  1725

  PDF: 634

  HTML: 285

• LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

  Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles

  e2020020

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.020

  1946

  PDF: 1204

  HTML: 337

• How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

  Marco Sanna, Giovanni Caocci, Giorgio La Nasa

  e2017047

  2017-08-14

  https://doi.org/10.4084/mjhid.2017.047

  1894

  PDF: 943

  HTML: 1018

  Referring article: 777

• IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

  Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay

  e2022053

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.053

  1092

  PDF: 743

  HTML: 276

• MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

  Maria Ilaria Del Principe

  e2016052

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.052

  5112

  PDF: 1351

  HTML: 1933

  Untitled: 209

  Untitled: 196

• Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma

  Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser

  e2012063

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.063

  1528

  PDF: 755

  HTML: 4595

  Figure 1: Chest radiograph: 235

  Figure 2: Flow cytometer analysis of pleural fluid: 206

• INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

  Giuseppe La Torre

  e2016044

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.044

  4791

  PDF: 1530

  HTML: 3439

• PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

  Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag

  e2011055

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.055

  1943

  PDF: 778

  HTML: 1575

• Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

  Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso

  e2024048

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.048

  1108

  PDF: 1028

  HTML: 164

• DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

  Sabina Chiaretti, Gina Zini, Renato Bassan

  e2014073

  2014-10-24

  https://doi.org/10.4084/mjhid.2014.073

  9327

  PDF: 6205

  HTML: 88074

  Fig.1b: 221

  Fig.1c: 222

  Fig.2a: 205

  Fig.2b: 204

  Fig.4: 226

  Fig.2c: 206

  Fig.3: 208

  Tab.1: 262

  Tab.2: 240

  Tab.3: 223

  Tab.4: 254

  Fig1a: 219

• Molecular Expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinase plasma cellular disorders: a molecular panel to investigate disease progression

  Maria Cristina Rapanotti

  e2018059

  2018-10-30

  https://doi.org/10.4084/mjhid.2018.059

  1401

  PDF: 829

  HTML: 202

• Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis

  Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci

  e2012035

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.035

  1659

  PDF: 785

  HTML: 662

• CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

  Daichi Inoue, Hayato Maruoka, Takayuki Takahashi

  e2010020

  2010-08-05

  https://doi.org/10.4084/mjhid.2010.020

  1351

  PDF: 771

  HTML: 1240

• Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

  Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani

  e2024004

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.004

  1525

  PDF: 1467

  HTML: 213

• MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

  Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar

  e2018002

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.002

  3735

  PDF: 1251

  HTML: 1115

• DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

  Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà

  e2018040

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.040

  3899

  PDF: 1347

  HTML: 903

  Figure 2: 483

  Figure 1: 3166

• MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

  Alfredo Marzano

  e2009025

  https://doi.org/10.4084/mjhid.2009.025

  889

  PDF: 497

  HTML: 1312

• Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

  Serdar Sivgin

  e2013006

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.006

  1200

  PDF: 656

  HTML: 3345

• ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

  Vincenzo De Sanctis

  e2017018

  2017-02-20

  https://doi.org/10.4084/mjhid.2017.018

  11558

  PDF: 4451

  HTML: 4887

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  2082

  PDF: 1732

  HTML: 381

• COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

  Jean Elcheikh

  e2015048

  2015-08-21

  https://doi.org/10.4084/mjhid.2015.048

  1983

  PDF: 1052

  HTML: 1387

• EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

  Pellegrino Musto, Dr. Nicola Sgherza

  e2024073

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.073

  1620

  PDF: 862

  HTML: 221

• FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

  Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo

  e2024029

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.029

  1037

  PDF: 1274

  HTML: 127

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3496

  PDF: 1652

  HTML: 679

• A PROSPECTIVE STUDY OF BRUCELLOSIS IN CHILDREN: RELATIVE FREQUENCY OF PANCYTOPENIA

  Mohamed El Koumi, Mona Afify, Salha Al-Zahrani

  e2013011

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.011

  2285

  PDF: 877

  HTML: 4033

• A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

  Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani

  e2012017

  2012-03-13

  https://doi.org/10.4084/mjhid.2012.017

  1307

  PDF: 675

  HTML: 802

• ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

  Mohamed L. Sorror, Rainer F. Storb

  e2010015

  2010-06-08

  https://doi.org/10.4084/mjhid.2010.015

  1050

  PDF: 662

  HTML: 2241

• HHVs AND LYMPHOPROLIFERATIVE DISORDERS

  C Quadrelli, P Barozzi, G Riva, Mario Luppi

  e2011043

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.043

  1472

  PDF: 855

  HTML: 3136